Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy

Rationale: Daily azithromycin decreases acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but long-term side effects are unknown. Objectives: To identify the types of exacerbations most likely to be reduced and clinical subgroups most likely to benefit from azithromycin, 250 mg...

全面介紹

Na minha lista:
書目詳細資料
發表在:Am J Respir Crit Care Med
Main Authors: Han, MeiLan K., Tayob, Nabihah, Murray, Susan, Dransfield, Mark T., Washko, George, Scanlon, Paul D., Criner, Gerard J., Casaburi, Richard, Connett, John, Lazarus, Stephen C., Albert, Richard, Woodruff, Prescott, Martinez, Fernando J.
格式: Artigo
語言:Inglês
出版: American Thoracic Society 2014
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226018/
https://ncbi.nlm.nih.gov/pubmed/24779680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201402-0207OC
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍